Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Erin Harvey to Treatment Outcome

This is a "connection" page, showing publications Erin Harvey has written about Treatment Outcome.

 
Connection Strength
 
 
 
0.206
 
  1. Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med. 2025 Nov; 248:108340.
    View in: PubMed
    Score: 0.086
  2. Hamada Y, Thomas D, McDonald VM, Harvey ES, Fricker M, Gillman A, Hew M, Kritikos V, Upham JW, Gibson PG. Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab. Ann Allergy Asthma Immunol. 2025 Nov; 135(5):537-546.e12.
    View in: PubMed
    Score: 0.021
  3. Hamada Y, Thomas D, Harvey ES, Stevens S, Fricker M, Lewthwaite H, McDonald VM, Gillman A, Hew M, Kritikos V, Upham JW, Gibson PG. Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. Eur Respir J. 2025 Jan; 65(1).
    View in: PubMed
    Score: 0.021
  4. Marinelli JP, Rahne T, Dornhoffer JR, Lohse CM, Cottrell J, Thomas Roland J, Thompson NJ, Brown KD, Lucas JC, Babu SC, Lindquist NR, Perkins EL, Tan D, Lane JI, Hunter JB, Harvey E, Deep NL, Cerasiello SY, Kircher ML, Espahbodi M, Tooker EL, West NC, Caye-Thomasen P, Carlson ML, Plontke SK. Cochlear Implantation With Sporadic Inner Ear Schwannomas: Outcomes in 106 Patients From an International Multi-Institutional Study. Otol Neurotol. 2025 Jan 01; 46(1):10-18.
    View in: PubMed
    Score: 0.020
  5. Dornhoffer JR, Marinelli JP, Lohse CM, Cottrell J, McMenomey SO, Roland JT, Thompson NJ, Brown KD, Lucas JC, Babu SC, Lindquist NR, Perkins EL, Rahne T, Plontke SK, Tan D, Hunter JB, Harvey E, Deep NL, Cerasiello SY, Kircher ML, Espahbodi M, Tooker EL, Lloyd SKW, Carlson ML. Comparing Cochlear Implant Outcomes in 100 Patients With Sporadic Vestibular Schwannoma Managed With Observation, Radiosurgery, or Microsurgery: A Multi-Institutional Review. Otol Neurotol. 2024 Dec 01; 45(10):e719-e726.
    View in: PubMed
    Score: 0.020
  6. Hamada Y, Gibson PG, Harvey ES, Stevens S, Lewthwaite H, Fricker M, McDonald VM, Gillman A, Hew M, Kritikos V, Upham JW, Thomas D. Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2025 Feb; 13(2):333-342.e9.
    View in: PubMed
    Score: 0.020
  7. Kritikos V, Harvey ES, Stevens S, Katelaris CH, Langton D, Rimmer J, Farah CS, Gillman A, Hew M, Radhakrishna N, Thomas D, Gibson PG. Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2023 03; 11(3):885-895.e13.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)